Serum Institute of India: Current Affairs, GK & News - 2020-2021

India-Bangladesh sign MoU on COVID-19 Vaccine

Published: November 5, 2020

On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights According to the agreement, initially 1.5 crore people will be vaccinated as each person requires ..

Month: 

Category: 

Topics: 

COVID-19 Vaccine: Serum Institute of India to produce additional 100 million doses for India

Published: September 29, 2020

The Serum Institute of India recently announced that it will produce additional 100 million COVID-19 vaccines for low- and middle- income countries by 2021. Highlights Earlier, the institute had committed to deliver 100 million vaccines. Now a total of 200 million doses of COVID-19 vaccines are to be delivered to India by 2021. The Institute ..

Month: 

Category: 

Topics: 

Phase-2 trials of Bharat Biotech vaccine to begin in September

Published: August 15, 2020

As reported by India Today, the phase I trial for the COVID 19 vaccine made by Bharat Biotech is complete and the Phase II of this trial is going to commence in September. In the first phase of the trial, the vaccine, known as Covaxin, is safe for human usage. Details of the Phase I ..

Month: 

Category: 

Topics: 

‘Covishield’ Vaccine to Start Trials in India

Published: July 22, 2020

The Serum Institute of India is going to launch its first COVID 19 vaccine candidate for trials very soon in India. The vaccine has been named as ‘Covishield’. It has been developed by the Oxford University and pharmaceutical giant, AstraZeneca. The Serum Institute is going to apply for the license for trials of the vaccine ..

Month: 

Category: 

Topics: 

First indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine Approved by DCGI

Published: July 15, 2020

The first-ever completely home-grown Pneumococcal Polysaccharide Conjugate Vaccine has been approved by the Drug Controller General of India. The vaccine has been developed by Serum Institute of India, Pune. Serum Institute of India is also involved in the development of COVID 19 vaccine. The DCGI had given approval earlier to Serum Institute of India to ..

Month: 

Category: 

Topics: 

Advertisement